# Proteomic Profiling of PTEN Inhibition on Periodontal Ligament Stem Cells

**Authors:** Suphalak Phothichailert, Nunthawan Nowwarote, Chatvadee Kornsuthisopon, Shinya Murakami, Supreda Suphanantachat Srithanyarat, Thanaphum Osathanon

PMC · DOI: 10.1016/j.identj.2026.109493 · 2026-03-20

## TL;DR

This study explores how inhibiting PTEN affects proteins in periodontal ligament stem cells, revealing changes linked to cell regeneration and signaling pathways.

## Contribution

The study provides novel proteomic insights into PTEN inhibition in periodontal ligament stem cells and its impact on regenerative pathways.

## Key findings

- PTEN inhibition upregulates proteins related to cytoskeletal dynamics, vesicular transport, and signal transduction.
- Downregulated proteins are linked to transcriptional and metabolic regulation and membrane trafficking.
- PTEN inhibition modulates MAPK and Wnt signaling pathways, suggesting a role in periodontal tissue regeneration.

## Abstract

Phosphatase and tensin homolog (PTEN) is a critical regulator of cell proliferation, differentiation, and inflammatory balance. However, its downstream proteomic effects in periodontal ligament stem cells (PDLSCs) remain poorly understood. This study aimed to elucidate the proteomic alterations induced by PTEN inhibition and identify potential molecular pathways underlying periodontal regeneration.

PDLSCs were treated with 5 μM VO-OHpic for 24 hours, followed by proteomic profiling using mass spectrometric analysis. The resulting proteomic data were analysed using Heatmapper, Metascape, and WebGestalt (WEB-based Gene Set Analysis Toolkit) databases, as well as Cytoscape, to evaluate protein expression patterns and protein–protein interaction networks.

Proteomic analysis identified 7,525 proteins across all samples, with 3,497 proteins commonly expressed between groups. In the VO-OHpic-treated cells, proteins related to cytoskeletal dynamics (ACTR2, FNDC3A), vesicular transport (GGA1, RAB9A), and signal transduction (TRAF3IP3, GJB3) were upregulated. Enrichment analysis identified potential biological pathways related to membrane trafficking, secretion, and regulation of MAPK and Wnt signalling. Conversely, proteins linked to transcriptional and metabolic regulation (GLIS3, PHGDH, NADSYN1) and membrane trafficking (SNX1, REEP1) were downregulated. Cytokine signalling and interferon pathways were explored as the potential pathways involved in these downregulated proteins.

In conclusion, PTEN inhibition by VO-OHpic was associated with proteomic changes in PDLSCs linked to regenerative phenotype, including the modulation of MAPK and Wnt signalling pathways alongside alterations in immune and metabolic pathways. These findings suggest that PTEN may function as a modulator balancing inflammatory regulation and differentiation processes, providing mechanistic insight into its potential role in periodontal tissue regeneration.

## Linked entities

- **Genes:** PTEN (phosphatase and tensin homolog) [NCBI Gene 5728], ACTR2 (actin related protein 2) [NCBI Gene 10097], FNDC3A (fibronectin type III domain containing 3A) [NCBI Gene 22862], GGA1 (golgi associated, gamma adaptin ear containing, ARF binding protein 1) [NCBI Gene 26088], RAB9A (RAB9A, member RAS oncogene family) [NCBI Gene 9367], TRAF3IP3 (TRAF3 interacting protein 3) [NCBI Gene 80342], GJB3 (gap junction protein beta 3) [NCBI Gene 2707], GLIS3 (GLIS family zinc finger 3) [NCBI Gene 169792], PHGDH (phosphoglycerate dehydrogenase) [NCBI Gene 26227], NADSYN1 (NAD synthetase 1) [NCBI Gene 55191], SNX1 (sorting nexin 1) [NCBI Gene 6642], REEP1 (receptor accessory protein 1) [NCBI Gene 65055]
- **Chemicals:** VO-OHpic (PubChem CID 66577002)

## Full-text entities

- **Genes:** TRAF3IP3 (TRAF3 interacting protein 3) [NCBI Gene 80342] {aka T3JAM}, PHGDH (phosphoglycerate dehydrogenase) [NCBI Gene 26227] {aka 3-PGDH, 3PGDH, HEL-S-113, NLS, NLS1, PDG}, TSHZ3 (teashirt zinc finger homeobox 3) [NCBI Gene 57616] {aka TSH3, ZNF537}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, INPP4B (inositol polyphosphate-4-phosphatase type II B) [NCBI Gene 8821], SNX1 (sorting nexin 1) [NCBI Gene 6642] {aka HsT17379, VPS5}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IKZF2 (IKAROS family zinc finger 2) [NCBI Gene 22807] {aka ANF1A2, HELIOS, ICHAD, IMDIA, ZNF1A2, ZNFN1A2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, INPP4A (inositol polyphosphate-4-phosphatase type I A) [NCBI Gene 3631] {aka INPP4, NEDGQS, TVAS1}, Sirt6 (sirtuin 6) [NCBI Gene 50721] {aka 2810449N18Rik, Sir2l6, mSIRT6}, CLEC1B (C-type lectin domain family 1 member B) [NCBI Gene 51266] {aka 1810061I13Rik, CLEC2, PRO1384, QDED721}, Sirt3 (sirtuin 3) [NCBI Gene 64384] {aka 2310003L23Rik, Sir2l3}, ZNF648 (zinc finger protein 648) [NCBI Gene 127665], EMC8 (ER membrane protein complex subunit 8) [NCBI Gene 10328] {aka C16orf2, C16orf4, COX4NB, FAM158B, NOC4}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Sirt7 (sirtuin 7) [NCBI Gene 209011], IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, ESRRA (estrogen related receptor alpha) [NCBI Gene 2101] {aka ERR1, ERRa, ERRalpha, ESRL1, NR3B1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, RAB9A (RAB9A, member RAS oncogene family) [NCBI Gene 9367] {aka RAB9}, Esrrb (estrogen related receptor, beta) [NCBI Gene 26380] {aka Err2, Errb, Estrrb, Nr3b2}, REEP1 (receptor accessory protein 1) [NCBI Gene 65055] {aka C2orf23, DSMA6, HMN5B, HMND12, HMNR6, SPG31}, GGA1 (golgi associated, gamma adaptin ear containing, ARF binding protein 1) [NCBI Gene 26088], IBSP (integrin binding sialoprotein) [NCBI Gene 3381] {aka BNSP, BSP, BSP II, BSP-II, SP-II}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, NR0B2 (nuclear receptor subfamily 0 group B member 2) [NCBI Gene 8431] {aka SHP, SHP1}, IDO1 (indoleamine 2,3-dioxygenase 1) [NCBI Gene 3620] {aka IDO, IDO-1, INDO}, GJB3 (gap junction protein beta 3) [NCBI Gene 2707] {aka CX31, DFNA2, DFNA2B, EKV, EKVP1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, NEK3 (NIMA related kinase 3) [NCBI Gene 4752] {aka HSPK36}, RAB6A (RAB6A, member RAS oncogene family) [NCBI Gene 5870] {aka RAB6}, ACTR2 (actin related protein 2) [NCBI Gene 10097] {aka ARP2}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, NADSYN1 (NAD synthetase 1) [NCBI Gene 55191] {aka VCRL3}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, NANOG (Nanog homeobox) [NCBI Gene 79923], RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, SAPCD2 (suppressor APC domain containing 2) [NCBI Gene 89958] {aka C9orf140, p42.3}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, GLIS3 (GLIS family zinc finger 3) [NCBI Gene 169792] {aka NDH, ZNF515}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Pten (phosphatase and tensin homolog) [NCBI Gene 19211] {aka 2310035O07Rik, A130070J02Rik, B430203M17Rik, MMAC1, PTENbeta, TEP1}, DRC12 (dynein regulatory complex subunit 12 homolog) [NCBI Gene 283152] {aka CCDC153}, DRD4 (dopamine receptor D4) [NCBI Gene 1815] {aka D4DR}, FNDC3A (fibronectin type III domain containing 3A) [NCBI Gene 22862] {aka FNDC3, HUGO, bA203I16.1, bA203I16.5}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}
- **Diseases:** prostate cancer (MESH:D011471), alveolar bone loss (MESH:D016301), tumorigenesis (MESH:D063646), cancer (MESH:D009369), inflammation (MESH:D007249), periodontitis (MESH:D010518), breast cancer (MESH:D001943)
- **Chemicals:** TCA (MESH:D014233), methionine (MESH:D008715), L-glutamine (MESH:D005973), SF1670 (MESH:C000619508), carboxylic acid (MESH:D002264), Ca (MESH:D002118), serine (MESH:D012694), bpVpic (MESH:C119540), PIP2 (MESH:D019269), 5muM (-), TRIzol (MESH:C411644), lipid (MESH:D008055), peptide (MESH:D010455), cysteine (MESH:D003545), phospholipids (MESH:D010743), DCU (MESH:C000948), formaldehyde (MESH:D005557), Mg (MESH:D008274), phosphatidylinositol-3,4,5-trisphosphate (MESH:C060974), NAD (MESH:D009243), ROS (MESH:D017382), Oil Red O (MESH:C011049), Alizarin Red S (MESH:C004468), Alizarin red (MESH:C010078), water (MESH:D014867), VO-OHpic (MESH:C000600334), Sr (MESH:D013324), CO2 (MESH:D002245)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13019790/full.md

---
Source: https://tomesphere.com/paper/PMC13019790